The actions of cyclic AMP and cyclic GMP in biological regulation appear to be unique and, in some instances, mutually opposing (Goldberg et al., 1973 (Goldberg et al., , 1975 by various drugs suggests that selective changes in cyclic nucleotide concentrations may be possible through alterations in the activity of specific phosphodiesterases. We have previously reported (Saeed et al. 1979u,b) that rat lung contains distinct low-K, forms of phosphodiesterases specific for cyclic AMP and cyclic GMP. The present investigation describes the effects of several cyclic nucleotides and their analogues, as well as a variety of drugs, on the activities of cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase in rat lung homogenate. The differential effects of these agents on the two classes of enzymes indicate that selective alteration of cyclic Table 1 . Inhibition of rat lung cyclic AMP phosphodiesterase and cyclic GMP phosphodiesteruse by various cyclic nucleotides and their derivatives Assay conditions were as described in the text. The concentration of either cyclic nucleotide was 1 p~. IC,,, concentration ( p~) producing 50% inhibition of phosphodiesterase calculated by least-squares regression analysis. N.A., not active. *P < 0.01, **P < 0.00 1 for significance of slope. xanthine nucleotide concentrations in the lung, through alteration in the activities of phosphodiesterases, seems to be possible. The effects of various compounds on the hydrolysis of cyclic AMP and cyclic GMP were examined on the supernatant from rat lung homogenate, which, like human lung (Bergstrand et al., 1977) , contains phosphodiesterases specific for 3' : 5'-cyclic purine nucleotides (Campbell & Oliver, 1972 : Saeed ef al., 19790). Phosphodiesterase activity was assayed at 37OC by the radioisotopic procedure of Thompson & Appleman (197 1) as modified by Boudreau & Drummond (1975) . In preliminary experiments, the enzyme concentration and the time of incubation were adjusted to ensure that no more than 25% of the cyclic nucleotides was hydrolysed under the assay conditions. None of the compounds examined affected the conversion of S'-nucleotides, by 5'-nucleotidase in the snake venom, into their corresponding nucleosides. All assays were performed in duplicate, and the values are corrected for those obtained in the absence of added phosphodiesterase. Table 1 In other experiments various drugs, some of which are known to inhibit the activities of phosphodiesterases from other sources, were studied for their effects on the rat lung and brain enzymes (Table 2 ). The most potent inhibition of cyclic GMP phosphodiesterase were 3-isobutyl-1 -methylxanthine and indomethacin compound. diclofenac, xanthine and indomethacin were most effective in inhibiting the cyclic AMP phosphodiesterase. Colchicine inhibited only the rat brain cyclic AMP phosphodiesterase.
This present study demonstrates differential inhibition of the two classes of phosphodiesterases by a variety of compounds. It is intriguing that compounds of such diverse structure are able to interact with the catalytic sites of two enzymes that so readily discriminate such similar structures as cyclic AMP and cyclic GMP. It may be concluded therefore that selective regulation of the tissue concentrations of respective cyclic nucleotides through specific or preferential inhibition of their enzyme activities seems to be possible.
